Avadel Pharmaceuticals Stock (NASDAQ: AVDL)

Avadel Pharmaceuticals (NASDAQ:AVDL) Stock, Unusual Options

Avadel Pharmaceuticals

Avadel Pharmaceuticals plc - Ordinary Share

Overview

News

Earnings

Options

Guidance

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Comments

Avadel Pharmaceuticals Unusual Options